Should access to fertility treatment be determined by female body mass index?

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Resource allocation towards fertility treatment has been extensively debated in countries where fertility treatment is publicly-funded. Medical, social and ethical aspects have been evaluated prior to allocation of resources. Analysis of cost-effectiveness, risks and benefits and poor success rates have led to calls of restricting fertility treatment to obese women. In this debate article, we critically appraise the evidence underlying this issue and highlight the problems with such a policy. Poor success rate of treatment is unsubstantiated as there is insufficient evidence to link high body mass index (BMI) to reduction in live birth. Obstetric complications have a linear relationship with BMI but are significantly influenced by maternal age. The same is true for miscarriage rates which are influenced by the confounding factors of polycystic ovary syndrome and age. Studies have shown that the direct costs per live birth are no greater for overweight and obese women. With changing demographics over half the reproductive-age population is overweight or obese. Restricting fertility treatment on the grounds of BMI would cause stigmatization and lead to inequity, feelings of injustice and social tension as affluent women manage to bypass these draconian restrictions. Time lost and poor success of conventional weight loss strategies would jeopardize the chances of conception for many women.
Original languageEnglish
Pages (from-to)815-820
Number of pages6
JournalHuman Reproduction
Volume25
Issue number4
Early online date3 Feb 2010
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Fertility
Body Mass Index
Resource Allocation
Live Birth
Therapeutics
Stereotyping
Polycystic Ovary Syndrome
Maternal Age
Spontaneous Abortion
Obstetrics
Cost-Benefit Analysis
Weight Loss
Emotions
Demography
Costs and Cost Analysis
Population

Keywords

  • body mass index
  • fertility treatment
  • IVF

Cite this

Should access to fertility treatment be determined by female body mass index? / Pandey, Shilpi; Maheshwari, Abha; Bhattacharya, Siladitya.

In: Human Reproduction, Vol. 25, No. 4, 04.2010, p. 815-820.

Research output: Contribution to journalArticle

@article{b0863d4a004040a0bc9b93d3a370e457,
title = "Should access to fertility treatment be determined by female body mass index?",
abstract = "Resource allocation towards fertility treatment has been extensively debated in countries where fertility treatment is publicly-funded. Medical, social and ethical aspects have been evaluated prior to allocation of resources. Analysis of cost-effectiveness, risks and benefits and poor success rates have led to calls of restricting fertility treatment to obese women. In this debate article, we critically appraise the evidence underlying this issue and highlight the problems with such a policy. Poor success rate of treatment is unsubstantiated as there is insufficient evidence to link high body mass index (BMI) to reduction in live birth. Obstetric complications have a linear relationship with BMI but are significantly influenced by maternal age. The same is true for miscarriage rates which are influenced by the confounding factors of polycystic ovary syndrome and age. Studies have shown that the direct costs per live birth are no greater for overweight and obese women. With changing demographics over half the reproductive-age population is overweight or obese. Restricting fertility treatment on the grounds of BMI would cause stigmatization and lead to inequity, feelings of injustice and social tension as affluent women manage to bypass these draconian restrictions. Time lost and poor success of conventional weight loss strategies would jeopardize the chances of conception for many women.",
keywords = "body mass index, fertility treatment, IVF",
author = "Shilpi Pandey and Abha Maheshwari and Siladitya Bhattacharya",
year = "2010",
month = "4",
doi = "10.1093/humrep/deq013",
language = "English",
volume = "25",
pages = "815--820",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "OXFORD UNIV PRESS",
number = "4",

}

TY - JOUR

T1 - Should access to fertility treatment be determined by female body mass index?

AU - Pandey, Shilpi

AU - Maheshwari, Abha

AU - Bhattacharya, Siladitya

PY - 2010/4

Y1 - 2010/4

N2 - Resource allocation towards fertility treatment has been extensively debated in countries where fertility treatment is publicly-funded. Medical, social and ethical aspects have been evaluated prior to allocation of resources. Analysis of cost-effectiveness, risks and benefits and poor success rates have led to calls of restricting fertility treatment to obese women. In this debate article, we critically appraise the evidence underlying this issue and highlight the problems with such a policy. Poor success rate of treatment is unsubstantiated as there is insufficient evidence to link high body mass index (BMI) to reduction in live birth. Obstetric complications have a linear relationship with BMI but are significantly influenced by maternal age. The same is true for miscarriage rates which are influenced by the confounding factors of polycystic ovary syndrome and age. Studies have shown that the direct costs per live birth are no greater for overweight and obese women. With changing demographics over half the reproductive-age population is overweight or obese. Restricting fertility treatment on the grounds of BMI would cause stigmatization and lead to inequity, feelings of injustice and social tension as affluent women manage to bypass these draconian restrictions. Time lost and poor success of conventional weight loss strategies would jeopardize the chances of conception for many women.

AB - Resource allocation towards fertility treatment has been extensively debated in countries where fertility treatment is publicly-funded. Medical, social and ethical aspects have been evaluated prior to allocation of resources. Analysis of cost-effectiveness, risks and benefits and poor success rates have led to calls of restricting fertility treatment to obese women. In this debate article, we critically appraise the evidence underlying this issue and highlight the problems with such a policy. Poor success rate of treatment is unsubstantiated as there is insufficient evidence to link high body mass index (BMI) to reduction in live birth. Obstetric complications have a linear relationship with BMI but are significantly influenced by maternal age. The same is true for miscarriage rates which are influenced by the confounding factors of polycystic ovary syndrome and age. Studies have shown that the direct costs per live birth are no greater for overweight and obese women. With changing demographics over half the reproductive-age population is overweight or obese. Restricting fertility treatment on the grounds of BMI would cause stigmatization and lead to inequity, feelings of injustice and social tension as affluent women manage to bypass these draconian restrictions. Time lost and poor success of conventional weight loss strategies would jeopardize the chances of conception for many women.

KW - body mass index

KW - fertility treatment

KW - IVF

U2 - 10.1093/humrep/deq013

DO - 10.1093/humrep/deq013

M3 - Article

VL - 25

SP - 815

EP - 820

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 4

ER -